Useful Links :
Why Publish with us :
- » Open Access Policy
- » Flexible Online Submission
- » Preliminary Quality Report within 3 days
- » 21 days Rapid Peer-Review
- » High Quality Publication
- » Global Promotion
- » Responsive Editorial Staff
- » Globally Recognized Journals
- » 24/7 Editorial Office Availability
Archives of Clinical and Experimental Pathology is an international peer-reviewed open access journal that aims to present clinical, medical, and experimental pathological studies and research. This journal deal strives to combine the research perspectives of both the fields of clinical pathology & experimental pathology also called investigative pathology. Thus, it deals with the diseases, their discovery, diagnosis, studies of prognosis and clinical implications of such diseases, and their relevance to modern medicine.
Archives of Clinical and Experimental Pathology intends to promote all the aspects of clinical and experimental pathology studies concerning etiology, pathogenesis, diagnosis of disease, clinical trials, and medical laboratory analysis; and cater to the needs of researchers, scientists, professionals, physicians, and students.
This journal providing an opportunity for the authors to make their contribution in form of Research Articles, Review Articles, Case Reports, Short Communications, Mini- Reviews, Opinions, etc. in the field of clinical and experimental research in pathology that encompasses diagnosis, prevention, and treatment of diseases.
The scope of the journal includes but is not limited to Anatomical Pathology, Clinical Virology, Cytogenetics, Clinical Pathology, Clinical Chemistry, Cytopathology, Diagnostic Immunology, Dermatopathology, Experimental Pathology, Forensic Pathology, Histopathology, Immunopathology, Molecular Pathology, Medical Microbiology, Neuropathology, Reproductive Biology, Surgical Pathology, Transfusion medicine, etc.
No Profit-Oriented Goal Setting, No Hidden Clues
We believe a manuscript is the ultimate form of contribution of a researcher for the betterment of the global community. Impactful researches should be available to global readers with no hindrance. We never claim Publication Fees beyond the limit of the researchers.
The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.
The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.
Managing Editor’s Role
Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.
Rapid and Fast Publication
All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.